drugset / Trial / NCT02091206
A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and pharmacokinetics (PK) of multiple doses of GWP42003-P compared with placebo in children with Dravet syndrome.
Timeline
- Start
- 2014-10-22
- Primary completion
- 2015-03-09
- Completion
- 2015-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 5 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 10 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 20 mg/kg | Oral |